For Healthcare Professionals: Lung Cancer

At Memorial Sloan Kettering we offer the latest innovations in lung cancer detection and therapy, including genetic testing of tumors and clinical trials of new therapies and drug combinations.

Our thoracic surgery team performs more lung cancer surgeries than any other medical center in the New York metropolitan area ─ more than 500 each year ─ ranking it among the highest-volume centers in the nation. Whenever possible, we use minimally invasive approaches, including robotic and video-assisted thoracic surgery (VATS), which are associated with faster recovery times than traditional open surgeries.

Refering a Patient

Call 866-218-8132
Mon–Fri, 8:30 AM–5:30 PM, ET

Find an Expert | See Clinical Trials | Request a Pathology Consult

#MSKthanks
MSK Named #1 by U.S. News

U.S. News & World Report named Memorial Sloan Kettering the top hospital for cancer care in the nation. We're honored, and patient care will always be our top priority.

#MSKthanks
Pictured: Martee Hensley
Screening Guidelines

Memorial Sloan Kettering screening guidelines for select patients involves low-dose helical CT of the chest at specific intervals.

Pictured: Martee Hensley
Lung Cancer Screening Decision Tool

Our lung cancer screening decision tool can help you understand the likelihood that screening will help you by calculating the chance you will develop lung cancer, and how likely it is that screening will prevent that from happening.

Pictured: Manjit Bains
Lung Cancer Information for Your Patients

The Memorial Sloan Kettering approach to diagnosis and treatment of lung cancer in patient-friendly language

Pictured: Manjit Bains

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Glomus Tumor at Tracheal Carina

Thoracic surgeon Robert Downey describes the diagnosis and treatment of a rare glomus tumor situated at the tracheal bifurcation in a male marathon runner.

Pictured: Paul Paik
Personalizing Treatment: Mutations Identified in Squamous Cell Lung Cancer Tumors

Medical oncologist Paul Paik discusses the Squamous Cell Carcinoma of the Lung Mutation Analysis Program (SQ-MAP) and various open clinical trials.

Tracheal Glomus
Pictured: Paul Paik
Squamous Cell Lung Mutations